Congenital Antithrombin Deficiency
Congenital Antithrombin Deficiency is a rare genetic disorder that affects the body's ability to regulate blood clotting, leading to an increased risk of abnormal blood clots.
Atenativ for Congenital Antithrombin Deficiency During Surgery
We are studying how Atenativ may help patients with congenital antithrombin deficiency during surgical procedures or childbirth. The trial looks at its safety, effectiveness, and how the body processes the medication.
>2 years6-10 visitsConfirmation phase (III)No PlaceboInvestigational MedicinesInjectionGynecology and ObstetricsHematologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have congenital antithrombin deficiency (low antithrombin levels)?
- Have you had any blood clots or related issues in the past 6 months?
- Have you had any surgery in the last 6 weeks?
- Are you currently pregnant or breastfeeding?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Atenativ
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical University Of Vienna
Department of Medicine I, Clinical Division of Haematology and Haemostaseology
Vienna, Austria
Nemocnice Nymburk, s.r.o.
Centrum pro trombozu a hemostazu
Nymburk, Czechia
Hospices Civils De Lyon
Unite d Hemostase Clinique - CRTH
Bron, France
Sponsor: Octapharma AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.